SCHEMBL6401268

SCHEMBL6401268

CCOC(=O)[C@@]1(C)CSC(c2ccccc2)=N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
ALOX5 P09917 1/20 0.40
OPRD1 P41143 3/20 0.39
OPRK1 P41145 3/20 0.39
SLC22A1 O15245 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
KCNH2 Q12809 1/20 0.39
ALDH1A1 P00352 3/20 0.39
RAB9A P51151 3/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 2/20 0.39
CDC7 O00311 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315068 1.00 OPRM1 (0.40) OPRM1SMN1; SMN2ALOX5OPRD1OPRK1
SCHEMBL5711331 0.85 MEN1 (0.41) OPRM1SMN1; SMN2ALOX5ALDH1A1RAB9A
SCHEMBL3958398 0.81 THRB (0.34) SMN1; SMN2ALOX5ALDH1A1RAB9AMAPT
SCHEMBL6825809 0.79 ALOX5 (0.44) SMN1; SMN2ALOX5ALDH1A1RAB9AGAA
SCHEMBL3304049 0.79 CA12 (0.38) OPRM1SMN1; SMN2ALDH1A1RAB9AGAA
SCHEMBL5914850 0.78 ALOX5 (0.38) OPRM1SMN1; SMN2ALOX5OPRD1OPRK1
SCHEMBL5914826 0.78 SMN1; SMN2 (0.37) OPRM1SMN1; SMN2ALOX5OPRD1OPRK1
SCHEMBL1534254 0.77 CA12 (0.42) SMN1; SMN2ALDH1A1GAAMAPTKDM4E
SCHEMBL20175941 0.77 ALDH1A1 (0.35) OPRM1SMN1; SMN2ALDH1A1RAB9AGAA
SCHEMBL20176128 0.74 KMT2A (0.40) SMN1; SMN2ALDH1A1RAB9AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894170-B2 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2005-05-17 US disclosed
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates KRICH SYLVIA (AT) 2005-05-12 US disclosed
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, RCOR1, MT-CO1 OPRM1 622/4885SMN1; SMN2 1442/4885ALOX5 2333/4885
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, CBR3, MT-CO1 OPRM1 649/4885SMN1; SMN2 1982/4885ALOX5 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.